ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G. Kemps, Brianna Empringham, Jennifer Picarsic et al.|Blood|2021Cited by 157
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Ulrich Keller, Osnat Bairey et al.|European Journal of Cancer|2023Cited by 8
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosisPaul G. Kemps, Jean‐François Emile, Jennifer Picarsic et al.|Blood Cancer Journal|2026Cited by 1